BRD2 and Alzheimer disease: To investigate whether FSH preferentially stimulates AD pathologies in an ApoE4-dependent manner, we employed both ApoE3-TR and ApoE4-TR female mice (4 months old), which were treated with FSH consecutively for 3 months.